Browse: Departments Dates Agencies
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
CFR Citation: 21 CFR Part 558
NOTICE: RULES
ACTION: Animal drugs, feeds, and related products:
DOCUMENT ACTION: Final rule.
SUBJECT CATEGORY: New Animal Drugs for Use in Animal Feeds; Monensin and Tylosin
DATES: This rule is effective March 23, 2001.
DOCUMENT SUMMARY: The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of two supplemental new animal drug applications (NADA's) filed by Elanco Animal Health. These supplemental NADA's provide for using tylosin or monensin and tylosin singleingredient Type A medicated articles to make tylosin liquid Type B medicated feeds or combination drug liquid Type B medicated feeds. The liquid Type B medicated feeds are used to make dry Type C medicated feeds for cattle.
SUMMARY: Monensin and tylosin,
SUPPLEMENTAL INFORMATION
Elanco Animal Health, A Division of Eli Lilly & Co., Lilly Corporate Center, Indianapolis, IN 46285, filed supplemental NADA 12491 that provides for use of TYLAN558.355 and 558.625 to reflect the approval.
The agency has determined under 21 CFR 25.33(a)(1) that these actions are of a type that do not individually or cumulatively have a significant effect on the human environment. Therefore, neither an environmental assessment nor an environmental impact statement is required.
This rule does not meet the definition of ``rule'' in 5 U.S.C.
804(3)(A) because it is a rule of ``particular applicability.''
Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801808.
List of Subjects in 21 CFR Part 558
Animal drugs, Animal feeds.
Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR part 558 is amended as follows:
PART 558NEW ANIMAL DRUGS FOR USE IN ANIMAL FEEDS
1. The authority citation for 21 CFR part 558 continues to read as follows:
Authority: 21 U.S.C. 360b, 371.
2. Section 558.355 is amended in paragraph (f)(3)(ii)(b) by adding
a new sentence after the second sentence to read as follows: Sec. 558.355 Monensin.
* * * * *
(f) * * *
(3) * * *
(ii) * * *
(b) * * * Combination drug liquid Type B medicated feeds may be
used to manufacture dry Type C medicated feeds and shall conform to mixing instructions as in Sec. 558.625 (c).
* * * * *
3. Section 558.625 is amended by adding paragraph (c) to read as follows:
Sec. 558.625 Tylosin.
* * * * *
(c) Special considerations. (1) Type C medicated feeds for cattle
may be manufactured from tylosin liquid Type B medicated feeds which
have a pH between 4.5 and 6.0 and which bear appropriate mixing directions as follows:
(i) For liquid Type B feeds stored in recirculating tank systems:
Recirculate immediately prior to use for no fewer than 10 minutes,
moving not less than 1 percent of the tank contents per minute from the
bottom of the tank to the top. Recirculate daily as described even when not used.
(ii) For liquid Type B feeds stored in mechanical, air, or other
agitationtype tank systems: Agitate immediately prior to use for no
fewer than 10 minutes, creating a turbulence at the bottom of the tank
that is visible at the top. Agitate daily as described even when not used.
(2) Tylosin liquid Type B medicated feeds used to make Type C
medicated feeds for cattle may be manufactured from tylosin Type A
medicated articles according to the following mixing directions:
(i) Presolubilize tylosin in 50 percent urea for approximately 1
hour prior to adding any feed components or other active ingredients. (ii) Maintain a pH between 4.5 and 6.0.
(3) Tylosin liquid Type B medicated feeds must bear an expiration date of 8 weeks after the date of manufacture.
* * * * *
Dated: March 8, 2001.
Claire M. Lathers,
Director, Office of New Animal Drug Evaluation, Center for Veterinary Medicine.
[FR Doc. 017182 Filed 32201; 8:45 am]
BILLING CODE 416001S
FOR FURTHER INFORMATION CONTACT Daniel A. Benz, Center for Veterinary Medicine (HFV126), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 3018270223.
Common CFR Searches
14 CFR Part 39 40 CFR Part 52 14 CFR Part 71 33 CFR Part 165 50 CFR Part 679 26 CFR Part 1 40 CFR Part 180 47 CFR Part 73 50 CFR Part 17 33 CFR Part 117 44 CFR Part 67 50 CFR Part 648 14 CFR Part 97 33 CFR Part 100 40 CFR Part 63 50 CFR Part 622 26 CFR Part 301 39 CFR Part 111 40 CFR Part 300 50 CFR Part 660 44 CFR Part 65 40 CFR Parts 52 and 81 40 CFR Part 271 47 CFR Part 64 50 CFR Part 665 47 CFR Part 76 50 CFR Part 229 14 CFR Part 23 14 CFR Part 25 21 CFR Part 522